3-氨基-5-苯基噻吩-2-甲酸甲酯 | 100063-22-7

• 物质功能分类: 医药中间体 - 杂环化合物 - 噻吩类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 中文名称: 3-氨基-5-苯基噻吩-2-甲酸甲酯
• 中文别名: 3-氨基-5-苯基噻吩-2-羧酸甲酯；3-氨基-5-苯基-2-噻吩羧酸甲酯；3-氨基-5-苯噻吩-2-羧酸甲酯；2-氨基-4-苯噻吩-3-羧酸甲酯
• 英文名称: methyl 3-amino-5-phenylthiophene-2-carboxylate
• CAS: 100063-22-7
• 化学式: C₁₂H₁₁NO₂S
• mdl: MFCD00068161
• 分子量: 233.291
• InChiKey: QESSCNMSOLRYBO-UHFFFAOYSA-N

物化性质

• 熔点：
  147 °C
• 沸点：
  442.5±45.0 °C(Predicted)
• 密度：
  1.265±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  在常温常压下保持稳定，应避免与碱性和氧化剂接触。

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.083
• 拓扑面积：
  80.6
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S24/25
• 危险类别码：
  R36/37/38
• 危险标志：
  GHS07
• 危险性描述：
  H302
• 危险性防范说明：
  P261,P301+P312,P302+P352,P304+P340,P305+P351+P338
• 储存条件：
  密封保存于阴凉、干燥的仓库中，并远离氧化物和碱性物质。

SDS

Name:	Methyl 3-amino-5-phenylthiophene-2-carboxylate 97% Material Safety Data Sheet
Synonym:
CAS:	100063-22-7

Section 1 - Chemical Product MSDS Name:Methyl 3-amino-5-phenylthiophene-2-carboxylate 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
100063-22-7	Methyl 3-amino-5-phenylthiophene-2-car	97	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 100063-22-7: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 145 - 148 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C12H11NO2S
Molecular Weight: 233

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, acid chlorides.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 100063-22-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Methyl 3-amino-5-phenylthiophene-2-carboxylate - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 100063-22-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 100063-22-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 100063-22-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质：黄色结晶体。

反应信息

• 作为反应物：
  描述：

  3-氨基-5-苯基噻吩-2-甲酸甲酯 在 sodium hydroxide 、 氯化亚砜 、 氨 作用下， 以 甲醇 、 乙腈 为溶剂， 生成 3-氨基-5-苯基-2-噻吩甲酰胺
  参考文献：
  名称：

  Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors

  摘要：

  A hit-to-lead optimisation programme was carried out on the thiophenecarboxamide high throughput screening hits 1 and 2 resulting in the discovery of the potent and orally bioavailable IKK-2 inhibitor 22. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2004.03.058
• 作为产物：
  描述：

  苯胺 在 氢溴酸 、 sodium methylate 、 sodium nitrite 作用下， 以 甲醇 、 水 为溶剂， 反应 1.08h， 生成 3-氨基-5-苯基噻吩-2-甲酸甲酯
  参考文献：
  名称：

  2-溴-2-氯-3-芳基丙腈作为C-3合成子合成功能化的3-氨基噻吩

  摘要：

  Meerwein反应可制得2-Bromo-2-氯3--3-芳基丙腈，并被证明是合成噻吩官能化的3-aminothiophenes的有用原料。

  DOI：

  10.1002/ejoc.201901512

文献信息

• [EN] THIENOPYRAZOLES<br/>[FR] THIENOPYRAZOLES
  申请人：AVENTIS PHARMA INC

  公开号：WO2005026175A1

  公开（公告）日：2005-03-24

  Thienopyrazoles, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).

  噻唑并吡唑类化合物，其制备方法，包含这些化合物的药物组合物，以及它们在治疗可通过抑制蛋白激酶，特别是白细胞介素-2诱导酪氨酸激酶（ITK）而调节的疾病状态中的药用。
• Anti-infective agents
  申请人：——

  公开号：US20040087577A1

  公开（公告）日：2004-05-06

  Compounds having the formula 1 are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

  具有公式1的化合物是丙型肝炎（HCV）聚合酶抑制剂。还公开了一种用于抑制丙型肝炎（HCV）聚合酶的组成和方法，用于制造这些化合物的过程，以及在这些过程中使用的合成中间体。
• Reductive Alkylation of Aromatic Amines with Enol Ethers
  作者：T. Jagadeeswar Reddy、Michael Leclair、Melanie Proulx

  DOI：10.1055/s-2005-863704

  日期：——

  Reductive alkylation of aromatic amines with 2-meth­oxypropene using 1.0 equivalent of HOAc and NaBH(OAc)3 in 1,2-dichloroethane (DCE) at room temperature furnished N-isopropyl amines in 50-98% yields. This method was successfully extended to trimethylsilyl enol ethers. The mild reaction conditions provide a new alternative procedure for the reductive amination of electron deficient aromatic amines

  在室温下，在 1,2-二氯乙烷 (DCE) 中使用 1.0 当量的 HOAc 和 NaBH(OAc) 3 对芳香胺与 2-甲氧基丙烯进行还原烷基化，以 50-98% 的产率提供 N-异丙基胺。该方法成功地扩展到三甲基甲硅烷基烯醇醚。温和的反应条件为缺电​​子芳香胺的还原胺化提供了一种新的替代方法。
• [EN] COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS<br/>[FR] COMPOSES ET PROCEDES DE TRAITEMENT OU DE PREVENTION D'INFECTIONS A FLAVIVIRUS
  申请人：VIROCHEM PHARMA INC

  公开号：WO2004052885A1

  公开（公告）日：2004-06-24

  The present invention provides novel compounds represented by formula (I) or pharmaceutically acceptable salts thereof useful for treating flaviviridae viral infection.

  本发明提供了一种表示为式(I)的新化合物，或其在药学上可接受的盐，用于治疗黄病毒科病毒感染。
• [EN] INHIBITORS OF HEPATITIS C VIRUS POLYMERASE<br/>[FR] INHIBITEURS DE LA POLYMÉRASE DU VIRUS DE L'HÉPATITE C
  申请人：COCRYSTAL DISCOVERY INC

  公开号：WO2012083105A1

  公开（公告）日：2012-06-21

  The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

  本发明提供了一种由一般式（I）表示的化合物及其药用盐，其中X、Y、R1A、R1B、R2和R3如本文中的类和子类中所定义，并包括含有这种化合物的组合物（例如，药物组合物），这些化合物可用作丙型肝炎病毒聚合酶的抑制剂，因此可用作治疗HCV感染的药物。